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NMRa b s t r a c t
The sigma-1 receptor (S1R) is a ligand-regulated membrane chaperone protein associated with
endoplasmic reticulum stress response, and modulation of ion channel activities at the plasma
membrane. We report here a solution NMR study of a S1R construct (S1R(D35)) in which only the
ﬁrst transmembrane domain and the eight-residue N-terminus have been removed. The second
transmembrane helix is found to be composed of residues 91–107, which corresponds to the ﬁrst
steroid binding domain-like region. The cytosolic domain is found to contain three helices, and
the secondary structure and backbone dynamics of the chaperone domain are consistent with that
determined previously for the chaperone domain alone. The position of TM2 provides a framework
for ongoing studies of S1R ligand binding and oligomerisation.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
The sigma-1 receptor (S1R) is a membrane chaperone protein
present varyingly in both the endoplasmic reticulum (ER) and
plasma membranes, where it functions as an accessory protein to
a number of ion channels and receptors [1–3]. S1R has been
observed to modulate the activity of several ion channels including
IP3 receptors [2,4] and voltage-gated channels selective for potas-
sium [5,6], sodium [7], and calcium [8]. S1R has also been shown to
interact with acid-sensing ion channels [9], glutamate receptors
[10], and dopamine receptors [11]. S1R is highly expressed in the
central nervous system (CNS), primarily in the cerebral cortex, hip-
pocampus and cerebellar Purkinje cells [12,13], and binds a large
number of small molecules (opiates, antipsychotics, antidepres-
sants, antihistamines, phencyclidine-like compounds, b-adrenergic
receptor ligands, cocaine, dimethyltryptamine, progesterone, and
sphingosine), many of which have been shown to modulate the
effect of S1R on receptors and ion channels (reviewed in [14,15]).
Thus, S1R is a potential therapeutic target in the treatment of a
range of diseases of the CNS, including schizophrenia, Alzheimer’s
and Parkinson’s diseases, amnesia, depression, amyotrophic lateral
sclerosis and addiction.
S1R contains two transmembrane domains connected by a
cytosolic domain, and an ER-accessible C-terminal chaperonedomain [1,6]. Based on homology to the steroid binding regions
of fungal sterol C7–C8 isomerases, the regions from residues
91–109 and 176–194 have been termed Steroid Binding Domain
Like I and II (SBDLI and SBDLII, respectively), and shown by
mutagenesis and chemical derivatisation studies to be located
within the S1R ligand binding site [16,17].
In addition, several residues immediately N-terminal to SBDL1
have been implicated in S1R oligomerisation, including a ﬁve
amino acid sequence (GGWMG; residues 87–91) proposed to con-
tain a glycophorin A-like GxxxG intramembrane dimerisation
motif [18,19]. S1R oligomerisation is ligand dependent and may
provide a mechanism by which its activity is regulated [18,20].
An oligomerisation interface at or near SBDLI would provide an
obvious structural link to drug binding.
Whereas SBDLII is centered on helix 3 of the membrane
associated chaperone domain [17,21], the structure of the region
encompassing SBDLI and its relationship to the membrane is not
known. Sequence-based predictions of transmembrane helices
indicate that SBDLI will have at least some overlap with the
second transmembrane helix (TM2). However, these predictions
do not converge on a single position for TM2 (Table 1). Of the
algorithms tested, some indicate the presence of a transmembrane
helix between residues 80–100, whereas others locate it between
residues 90–110, and at least one algorithm fails to conﬁdently
identify any transmembrane helix in this region.
Because of the importance of SBDLI and the adjacent region in
ligand binding and receptor oligomerisation, deﬁning the residues
that constitute TM2 can shed light on the structural link between
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S1R chaperone domain could be reconstituted into DPC detergent
micelles as a monomeric species capable of binding the ER chaper-
one BiP [21]. The S1R chaperone domain was found to contain ﬁve
helices (H1–H5) and a ﬂexible internal region of 30 amino acids
containing at least two regions with propensity to adopt an
extended conformation. The fourth helix in the chaperone domain
is amphipathic and likely drives its association with membranes.
Here we report solution NMR studies of a novel S1R construct
(S1R(D35)) in which the ﬁrst transmembrane domain has been
removed, enabling a description of the residues within the TM2
helix and the secondary structure of the cytosolic domain. We
show that the topology and backbone dynamics of natively
puriﬁed S1R(D35) is consistent with that determined previously
for the chaperone domain [21], that TM2 consists of residues
91–107, and that the cytosolic region contains three helices
(cH1–cH3). Identiﬁcation of the TM2 residues provides a frame-
work for further studies of S1R ligand binding and oligomerisation.
2. Materials and methods
2.1. Protein sample production
An ACA-free gene construct (GeneArt) containing an N-terminal
(His)6-tag or a (His)9-tag, a Factor Xa cleavage site, and residues
36–223 of human S1R was subcloned into the pCOLD-I vector
(Takara) and conﬁrmed by sequencing. The substitution C94A,
shown to have no effect on ligand binding in full-length guinea
pig S1R [17], was introduced to prevent intermolecular disulﬁde
bond formation during puriﬁcation. The N-terminal sequence pre-
ceding the S1R residues 36–223 was MNHKVHHHHHHIEGRHM or
MNHKVHHHHHHHHHIEGRHM. The S1R(D35) plasmid and a
pMazF plasmid containing the gene for the RNA interferase MazF
(Takara) were transformed into C43(DE3) cells. Transformed cells
were grown to an OD600 of 0.8–0.9, cold shocked on ice, and incu-
bated for 45 min at 15 C. Cells were pelleted and washed with M9
salt solution, pelleted a second time, and then resuspended into a
10-fold lower volume of isotopically labeled media. Cells were
incubated for a further 45–60 min at 15 C before induction with
2.5 mM IPTG. Expression proceeded for 16 h at 15 C. Membranes
were collected by centrifugation at 200000g, and incubated
overnight in a solution containing 6 M guanidine, 200 mM NaCl,
1% Triton, and 20 mM Tris at pH 8.0. S1R(D35) was separated by
Ni afﬁnity chromatography and dialyzed against water to remove
guanidine. The precipitated protein was resolubilized in
hexaﬂuoro-2-propanol and puriﬁed by HPLC on a C3 reverse phase
column over a gradient from buffer A (95% water, 5% acetonitrile,
0.1% triﬂuoroacetic acid) to buffer B (57% 2-propanol, 38%Table 1
Sequence-based predictions of S1R transmembrane domains.
Algorithm TM1 (residues) TM2 (residues) Refs.
DAS 12–29 99–107 [34]
HMMTOP 13–37 83–107 [35]
Membrain 8–27 89–108 [36]
MEMSAT-SVM 15–30 91–106 [37]
PHOBIUS 9–30 89–111 [38]
PRED-TMR2 9–30 81–100 [39]
SOSUI 13–34 86–108 [40]
SPOCTOPUS 9–29 88–108 [41]
TMHMM 9–31 89–111a [42]
TMMOD 12–32 Not predicted [43]
TMpred 9–28 81–101 [44]
a TMHMM indicated an increased transmembrane helix probability for these
residues, but did not identify it as a transmembrane domain.acetonitrile, 5% water, 0.1% triﬂuoroacetic acid). Fractions contain-
ing S1R(D35) were pooled and lyophilized. For the native puriﬁca-
tion, the resuspended membranes were incubated overnight with
1% dodecylphosphocholine (DPC). The solubilized membranes
were puriﬁed by Ni afﬁnity chromatography in 20 mM DPC and
subsequently gel ﬁltrated into a low DPC concentration (3.3 mM)
in a Superdex200 column (GE). Both methods yielded approxi-
mately 40 mg of pure protein per liter of labeled media. The lipid
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) was added
from powder to the sample to a q ratio of 0.1, where q = [lipid]/
[detergent].
2.2. Circular dichroism
Samples for circular dichroism (CD) contained 12.6 or 7.3 lM
protein of S1R(cd) or S1R(D35), respectively, in DPC:DPPC mixed
micelles at a q ratio of 0.1, and 20 mM potassium phosphate at
pH 6.5. CD spectra were collected at room temperature on a Jasco
J-815 circular dichroism spectropolarimeter from 250 to 200 nm
with 10 accumulations. Data were smoothed with a Savitsky–
Golay ﬁlter [22] using a window of 11 points and then corrected
for concentration and number of residues.
2.3. NMR spectroscopy and data analysis
NMR experiments for resonance assignments were recorded on
2H, 15N, and 13C labeled samples in DPC:DPPC mixed micelles at a q
ratio of 0.1, in 20 mM potassium phosphate at pH 6.5. Spectra were
recorded at 600 MHz (1H) on a Bruker Avance III HD spectrometer
equipped with a TCI CryoProbe at 41 C. Backbone resonance
assignments were obtained for 160 of the 181 non-proline S1R res-
idues using a conventional set of TROSY-based experiments
(HNCA, HNCACB, CBCA(CO)NH and HNCO) collected with non-uni-
form sampling (NUS). For NUS, random sampling schedules were
used, with typically 15% of the total number of points collected.
Spectra were reconstructed with compressed sensing using qMDD
[23], processed using NMRPipe [24], and analyzed using NMRView
[25]. The assigned chemical shifts have been desposited to the
BMRB with accession code 25410.
The secondary structure of S1R(D35) was predicted from back-
bone 1HN, 15N, 13C, 13Ca and sidechain 13Cb chemical shifts using
TALOS-N [26]. 15N R1, R2 and 1H–15N heteronuclear NOE values
were measured with TROSY-based sequences collected on a
0.4 mM 15N, 13C-labeled S1R(D35) sample at 600 MHz using the
following relaxation delays: 10, 175, 350 and 525 ms (R1), and 0,
17, 51 and 85 ms (R2). The recycle delays for R1, R2 and heteronu-
clear NOE experiments were 1.5 s.
3. Results
The S1R(D35) construct contains the cytosolic domain, the
region of the second transmembrane domain, and the chaperone
domain, but lacks the ﬁrst transmembrane domain (predicted in
residues 9–30) and approximately eight lumenal, N-terminal resi-
dues. S1R(D35) was reconstituted for NMR studies either from
inclusion bodies or from the Escherichia coli membranes (Fig. 1A).
Well resolved backbone amide NMR spectra of S1R(D35) could
be obtained in mixed micelles containing the detergent DPC and
relatively small amounts of the lipid DPPC. By contrast, a subset
of the resonances for S1R(D35) in DPC alone were weak or missing,
indicating conformational exchange. The assigned backbone amide
resonances are shown in Fig. 1B. No signiﬁcant chemical shift dif-
ferences were observed between reconstituted S1R(D35) puriﬁed
from membranes or inclusion bodies. The effective size of the pro-
tein in DPC micelles was assessed by SEC-MALS and TRACT [27]
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Fig. 1. (A) SDS–PAGE of a typical sample of S1R(D35) used for NMR studies. (B) Assigned NMR spectrum of S1R(D35). 1H, 15N TROSY-HSQC spectrum (600 MHz, 1H) of
S1R(D35) in 50 mM DPC, 5 mM DPPC at 41 C. Backbone amide resonance assignments are indicated. A table of chemical shifts is provided in the Supplementary information.
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a 29kDa complex. This is consistent with an S1R(D35) monomer
(theoretical mass of 23.3kDa) and several strongly bound detergent
molecules.
The secondary structure of the cytosolic domain of S1R(D35)
determined from chemical shifts consists of three helices: residues
41–49 (cH1), 55–67 (cH2), and 81–85 (cH3) (Fig. 2). The cytosolic
region is followed by a mostly hydrophobic helix between resides
91–107, which is long enough to traverse the ER membrane, and
therefore likely to be TM2. Residues 91–107 were predicted to be
in a transmembrane helix by more than half of the algorithms
tested (Table 1).
The chemical shifts for residues in common with the isolated
chaperone domain are largely unchanged in S1R(D35), and the sec-
ondary structure of the chaperone domain in S1R(D35) is similar to
that of the isolated chaperone domain construct [21]. The region
that was most affected by the addition of the 78 N-terminal resi-
dues of the native sequence is H1 of the chaperone domain. In
S1R(cd), this helix is longer (residues 121–137), but conforma-
tional exchange was observed in the C-terminal region. In
S1R(D35), the helix ends at about residue 130 and the remaining
residues exhibited a mixed propensity for helical and extended
conformations. In addition, a third region (residues 160–164) in
the chaperone domain of S1R(D35) was found to have a high pro-
pensity for an extended conformation, in addition to the two
regions previously indicated by studies of the isolated chaperone
domain [21].
The secondary structure composition was probed by far UV CD
(Fig. 3). The CD spectrum of S1R(D35) exhibited a similar helicalcontent per residue as S1R(cd), consistent with their similar per-
cent-wise composition calculated from NMR chemical shifts (42%
and 46% for S1R(D35) and S1R(cd), respectively).
The backbone ﬂexibility of S1R(D35) was evaluated by mea-
suring 1H–15N heteronuclear NOEs and the ratio of the 15N trans-
verse (R2) and longitudinal relaxation rates (R1), both of which
decrease with increased internal dynamics (Fig. 4). Small hetero-
nuclear NOEs and low R2/R1 values were observed for a large
number of residues within the region 140–165, indicating that
the fast, picosecond to nanosecond time scale motions that were
previously observed here for the isolated chaperone domain [21]
are maintained in the longer construct. In addition, lower than
average R2/R1 values were found in the loops between the cyto-
solic helices cH1 and cH2, and between cH2 and cH3, indicating
ﬂexibility.
To further validate the secondary structure-based delineation of
TM2, DPPC was titrated into a S1R(D35) sample containing only
DPC micelles to a q ratio of 1 (Fig. 5). Assuming that lipids prefer-
entially solvate the natively transmembrane regions of the protein,
the predominant chemical shift perturbations are expected to
occur at the edges of the transmembrane domain, where the phos-
phocholine headgroup of DPC is replaced by the phosphatidylcho-
line headgroup of DPPC. Similar to regions with no lipid contact,
few changes would be expected in the center of the transmem-
brane domain because the hydrocarbon chains of the lipid and
the detergent are chemically similar. Upon addition of DPPC, the
largest clusters of perturbations were centered on residues 89
and 109, consistent with residues 91–107 forming the hydrophobic
core of TM2.
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Fig. 2. Chemical shift-based secondary structure analysis of S1R(D35). In the top plot, the TALOS-N [26] outputs are shown, in which the magnitude of the black bars above or
red bars below zero on the y-axis indicate the propensities for a-helical or extended conformations, respectively, and the propensities for an unstructured coil conformation
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Fig. 3. Far UV circular dichroism spectra of S1R(D35) (continuous line) and S1R(cd)
(dashed line) in 50 mM DPC, 5 mM DPPC in 5 mM potassium phosphate, pH 6.5,
plotted as the mean residue molar ellipticity per residue.
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S1R functions by regulating a wide range of ion channels and
receptors [15]. The activity of S1R itself depends on binding of
endogenous and exogenous compounds, and ligand binding has
been linked to receptor oligomerisation [18,20]. Possibly reﬂectingthe diversity of S1R protein–protein interactions, S1R ligands are in
clinical use or preclinical studies for a wide variety of diseases [28].
Despite the pharmacological interest in S1R, however, to date
structural information has only been available for the C-terminal
chaperone domain [21].
Of particular interest is the location and structure of the second
transmembrane domain because of its overlap with SBDLI
(residues 91–109) [16,17]. Sequence based predictions for TM2
are inconsistent (Table 1), however, predicting either residues
80–100 or 90–110, with some predictions being of very low
conﬁdence. Glycine residues at positions 87, 88 and 91 have been
implicated in ligand binding and receptor oligomerisation [18].
Therefore an accurate deﬁnition of TM2 has implications for
understanding how these residues participate in ligand binding
and possibly also S1R oligomerisation.
We have studied the N-terminal truncation mutant S1R(D35)
consisting of all residues from the start of the cytosolic domain
through to the chaperone domain, and therefore containing both
SBDLI and SBDLII and the glycines at positions 87, 88, and 91.
Chemical shift-based secondary structure determination and
lipid-induced chemical shift perturbations have been used to infer
the location of TM2. Although truncation of the ﬁrst transmem-
brane domain or S1R oligomerisation may lead to structural
changes, isolated a-helical transmembrane domains solubilized in
detergents are known to correlate strongly with that observed in
X-ray crystallographic structures of the intact proteins [29]. Our
results indicate that the S1R TM2 overlaps nearly completely with
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Fig. 4. Dynamic properties of S1R(D35) from relaxation and heteronuclear NOE collected at 600 MHz (1H) and 41 C. Top plot: the ratio of the 15N R2 and R1, as a function of
residue number for S1R(D35). Bottom plot: the 1H–15N heteronuclear NOEs. Residues K142 and S143 exhibited unusually large negative heteronuclear NOEs but were
excluded from the plot due to the large uncertainty in the data.
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G87 and G88 are in a linker connecting cH3 to TM2, although they
do not exhibit a large increase in ﬂexibility relative to the helical
regions. One possibility consistent with these results is that the
GGW sequence adopts a structured turn [30].
The position of TM2 determined here is in agreement with the
larger subset of transmembrane helix prediction algorithms (in par-
ticular, Membrain,MEMSAT-SVM, Phobius, SOSUI, SPOCTOPUS, and
TMHMM). The positioning of the helix is also consistent with
commonly used non-membrane predictors of a-helices: PSIPRED
predicts residues 89–107 to form a helix, and JPRED predicts
residues 91–104 to form a helix. However, the positioning is in
disagreement with a subset of the tested transmembrane helixprediction algorithms (Table 1). The lack of consensus in predicting
the position of TM2 is likely due to the presence of several polar res-
idues within the transmembrane domain. The center of TM2 is
highly amphipathic, with residues 96–104 (‘‘LHASLSEYV’’) having
a large, hydrophobic moment [31]. Interestingly, several of these
residues, including H97 [18], S99 and Y103 [32] have been impli-
cated in drug binding. In addition, the substitution E102Q has been
implicated in a form of amyotrophic lateral sclerosis and leads to
membrane mislocalisation of S1R in neuronal cells [33].
A comparison of the chaperone domain secondary structure in
S1R(D35) with that determined previously for the chaperone
domain on its own [21] indicates that the domain structure is lar-
gely maintained in the longer S1R(D35) construct. The largest
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Fig. 6. A schematic diagram of full-length S1R in a lipid bilayer showing the
secondary structure determined here for S1R(D35) construct. The loop preceding
TM2 contains G87, which is the ﬁrst residue in the GGWMG sequence, and is
indicated with an arrow. SBDLI corresponds closely to TM2 and SBDLII corresponds
to H3 and the adjacent coil regions. No experimental data for the ﬁrst transmem-
brane domain and N-terminus (colored gray) is available, although the ﬁrst
transmembrane domain is robustly predicted to be composed of the residues from
approximately 9 to 30.
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dynamic in S1R(D35), and residues 160–164, which have a stron-
ger propensity for an extended conformation in S1R(D35)
(Fig. 2). A comparison of the CD spectra for S1R(D35) and
S1R(cd) supports a similar proportion of a-helical structure in
the two constructs, consistent with that determined from the
NMR chemical shifts. In addition, comparison of CD spectra col-
lected in DPCmicelles and DPC:DPPCmixedmicelles indicated that
the helical regions of both S1R(cd) and S1R(D35) are stabilized
with the presence of lipid molecules [21].
In conclusion, we have characterized the secondary structure of
a construct of S1R missing only the eight residue N-terminus and
the ﬁrst transmembrane domain. Because the ﬁrst transmembrane
helix is robustly predicted (Table 1), a secondary structure sche-
matic of essentially the entire receptor can be made (Fig. 6). The
second transmembrane helix, TM2, was found to be composed of
residues 91–107, which corresponds closely to the SBDLI. The cyto-
solic domain contains three a-helices, and the secondary structure
of the chaperone domain was largely unchanged by the presence of
additional native S1R sequence. The third cytosolic helix (residues
81–85) was mobile compared with cH1 and cH2, and an only mod-
est increase in mobility of the GGW motif that joins cH3 to TM2
was observed. These ﬁndings facilitate interpretation of previous
results and will guide design of subsequent studies of the role of
TM2 in ligand binding and oligomerisation. These results also con-
stitute a signiﬁcant step toward a complete structure determina-
tion of S1R that will lead to a better atomic-level understanding
of S1R function.
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